1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with 2-(methylamino)isobutyric acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camps, M; Gumà, A; Palacín, M; Testar, X; Zorzano, A | 1 |
Ganapathy, V; Hatanaka, T; Huang, W; Martindale, RG | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and 2-(methylamino)isobutyric acid
Article | Year |
---|---|
Protein kinase C activators selectively inhibit insulin-stimulated system A transport activity in skeletal muscle at a post-receptor level.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-O-Methylglucose; Aminoisobutyric Acids; Animals; Biological Transport; Enzyme Activation; In Vitro Techniques; Insulin; Isoquinolines; Lactates; Male; Methylglucosides; Muscles; Piperazines; Polymyxin B; Protein Kinase C; Rats; Rats, Inbred Strains; Receptor, Insulin; Tetradecanoylphorbol Acetate | 1990 |
Differential influence of cAMP on the expression of the three subtypes (ATA1, ATA2, and ATA3) of the amino acid transport system A.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adjuvants, Immunologic; Amino Acid Transport Systems; Amino Acids; Aminoisobutyric Acids; Blotting, Northern; Carrier Proteins; Cholera Toxin; Colforsin; Cyclic AMP; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Poly A; Protein Binding; Protein Synthesis Inhibitors; RNA, Messenger; Sodium; Substrate Specificity; Time Factors; Tumor Cells, Cultured | 2001 |